In our previous study, monocytic myeloid-derived suppressor cells (Mo-MDSCs CD14+/HLADR−/low) and inflammatory monocytes (CD14+CD16+) displayed higher frequencies in RRMS patients when compared with HCs. Here, CD14 is linked to relapsing-remitting multiple sclerosis.